User profiles for Mara Gilardi

Mara Gilardi

Salk institute
Verified email at salk.edu
Cited by 1966

Human 3D vascularized organotypic microfluidic assays to study breast cancer cell extravasation

JS Jeon, S Bersini, M Gilardi, G Dubini… - Proceedings of the …, 2015 - National Acad Sciences
A key aspect of cancer metastases is the tendency for specific cancer cells to home to
defined subsets of secondary organs. Despite these known tendencies, the underlying …

Tumour-infiltrating B cells: immunological mechanisms, clinical impact and therapeutic opportunities

CM Laumont, AC Banville, M Gilardi, DP Hollern… - Nature Reviews …, 2022 - nature.com
Although immunotherapy research to date has focused largely on T cells, there is mounting
evidence that tumour-infiltrating B cells and plasma cells (collectively referred to as tumour-…

Tipifarnib as a Precision Therapy for HRAS-Mutant Head and Neck Squamous Cell Carcinomas

M Gilardi, Z Wang, M Proietto, A Chillà… - Molecular cancer …, 2020 - AACR
Tipifarnib is a potent and highly selective inhibitor of farnesyltransferase (FTase). FTase
catalyzes the posttranslational attachment of farnesyl groups to signaling proteins that are …

Microneedle-mediated intratumoral delivery of anti-CTLA-4 promotes cDC1-dependent eradication of oral squamous cell carcinoma with limited irAEs

M Gilardi, R Saddawi-Konefka, VH Wu… - Molecular cancer …, 2022 - AACR
Head and neck squamous cell carcinoma (HNSCC) ranks sixth in cancer incidence
worldwide and has a 5-year survival rate of only 63%. Immunotherapies—principally immune …

[HTML][HTML] Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4

Z Wang, VH Wu, MM Allevato, M Gilardi, Y He… - Nature …, 2019 - nature.com
Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide.
Tobacco use is the main risk factor for HNSCC, and tobacco-associated HNSCCs have …

The driving role of the Cdk5/Tln1/FAKS732 axis in cancer cell extravasation dissected by human vascularized microfluidic models

M Gilardi, S Bersini, S Valtorta, M Proietto, M Crippa… - Biomaterials, 2021 - Elsevier
Background Understanding the molecular mechanisms of metastatic dissemination, the
leading cause of death in cancer patients, is required to develop novel, effective therapies. …

[HTML][HTML] HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers

…, P Tamayo, JL Callejas-Valera, M Allevato, M Gilardi… - Oncogene, 2020 - nature.com
The dominant paradigm for HPV carcinogenesis includes integration into the host genome
followed by expression of E6 and E7 (E6/E7). We explored an alternative carcinogenic …

[PDF][PDF] Engineering an environment for the study of fibrosis: a 3D human muscle model with endothelium specificity and endomysium

S Bersini, M Gilardi, GS Ugolini, V Sansoni, G Talo… - Cell reports, 2018 - cell.com
The integration of vascular structures into in vitro cultured tissues provides realistic models
of complex tissue-vascular interactions. Despite the incidence and impact of muscle-wasting …

[HTML][HTML] Disruption of the HER3-PI3K-mTOR oncogenic signaling axis and PD-1 blockade as a multimodal precision immunotherapy in head and neck cancer

…, VH Wu, R Saddawi-Konefka, M Gilardi… - Nature …, 2021 - nature.com
Immune checkpoint blockade (ICB) therapy has revolutionized head and neck squamous
cell carcinoma (HNSCC) treatment, but <20% of patients achieve durable responses. …

Human in vitro 3D co-culture model to engineer vascularized bone-mimicking tissues combining computational tools and statistical experimental approach

S Bersini, M Gilardi, C Arrigoni, G Talò, M Zamai… - Biomaterials, 2016 - Elsevier
The generation of functional, vascularized tissues is a key challenge for both tissue engineering
applications and the development of advanced in vitro models analyzing interactions …